The Pennant Group, Inc. reported $1.10B of revenue over the trailing twelve months, +38% on the year before. 11 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $1.10B (to Q2 2026). Net income: $32M, trailing twelve months to Q2 2026. Free cash flow: $35M, trailing twelve months to Q2 2026. Operating margin: 5.6%, trailing twelve months to Q2 2026.

PNTGThe Pennant Group, Inc.

Healthcare

$39.72+65% 1Y

$39.72

$23.6452 weeks$42.50

PNTG as reported

The Pennant Group, Inc. reported $1.10B of revenue over the trailing twelve months, +38% on the year before. 11 reported series are charted on this page, each one as filed.

$1.10B

Revenue, trailing twelve months · to Q2 2026 · +38% against the twelve months before

Net income: $32M
Net income · +20% year on year · trailing twelve months to Q2 2026
Free cash flow: $35M
Free cash flow · +7.0% year on year · trailing twelve months to Q2 2026
Operating margin: 5.6%
Operating margin · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for PNTG, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$1.10B	+38%	Q2 2026
Net income	$32M	+20%	Q2 2026
EPS	$0.91	+17%	Q2 2026
Gross margin	19%	n/a	Q2 2026
Operating margin	5.6%	n/a	Q2 2026
Net margin	2.9%	n/a	Q2 2026
ROE	7.9%	n/a	Q2 2026
ROA	3.2%	n/a	Q2 2026
ROIC	8.4%	n/a	Q2 2026
Free cash flow	$35M	+7.0%	Q2 2026
P/E	43.6	n/a	today

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.